BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25706510)

  • 1. Interstitial deletion 5q14.3q21.3 associated with lethal epilepsy.
    Yang YJ; Yao X; Guo J; Zhao R; He XY; Zhao L; Tu M; Zhu YM
    Am J Med Genet A; 2015 Apr; 167A(4):866-71. PubMed ID: 25706510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?
    Fernández Hernández L; Alcántara Ortigoza MA; Ramos Angeles SE; González-Del Angel A
    Cytogenet Genome Res; 2021; 161(12):556-563. PubMed ID: 35021179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less.
    Tonk V; Kyhm JH; Gibson CE; Wilson GN
    Am J Med Genet A; 2011 Jun; 155A(6):1437-41. PubMed ID: 21567930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.
    Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T
    Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
    Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T
    Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel microdeletion syndrome involving 5q14.3-q15: clinical and molecular cytogenetic characterization of three patients.
    Engels H; Wohlleber E; Zink A; Hoyer J; Ludwig KU; Brockschmidt FF; Wieczorek D; Moog U; Hellmann-Mersch B; Weber RG; Willatt L; Kreiss-Nachtsheim M; Firth HV; Rauch A
    Eur J Hum Genet; 2009 Dec; 17(12):1592-9. PubMed ID: 19471318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
    Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
    J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdeletion 5q14.3 and anomalies of brain development.
    Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
    Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEF2C deletions and mutations versus duplications: a clinical comparison.
    Novara F; Rizzo A; Bedini G; Girgenti V; Esposito S; Pantaleoni C; Ciccone R; Sciacca FL; Achille V; Della Mina E; Gana S; Zuffardi O; Estienne M
    Eur J Med Genet; 2013 May; 56(5):260-5. PubMed ID: 23402836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5q14.3 Microdeletions: A Contiguous Gene Syndrome with Capillary Malformation-Arteriovenous Malformation Syndrome and Neurologic Findings.
    Park SM; Kim JM; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
    Pediatr Dermatol; 2017 Mar; 34(2):156-159. PubMed ID: 28297145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
    Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
    Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADGRV1 is implicated in myoclonic epilepsy.
    Myers KA; Nasioulas S; Boys A; McMahon JM; Slater H; Lockhart P; Sart DD; Scheffer IE
    Epilepsia; 2018 Feb; 59(2):381-388. PubMed ID: 29266188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periventricular heterotopia, mental retardation, and epilepsy associated with 5q14.3-q15 deletion.
    Cardoso C; Boys A; Parrini E; Mignon-Ravix C; McMahon JM; Khantane S; Bertini E; Pallesi E; Missirian C; Zuffardi O; Novara F; Villard L; Giglio S; Chabrol B; Slater HR; Moncla A; Scheffer IE; Guerrini R
    Neurology; 2009 Mar; 72(9):784-92. PubMed ID: 19073947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial MEF2C deletion in a Cypriot patient with severe intellectual disability and a jugular fossa malformation: review of the literature.
    Tanteles GA; Alexandrou A; Evangelidou P; Gavatha M; Anastasiadou V; Sismani C
    Am J Med Genet A; 2015 Mar; 167A(3):664-9. PubMed ID: 25691421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial deletion 5p14.1-p15.2 and 5q14.3-q23.2 in a patient with clubfoot, blepharophimosis, arthrogryposis, and multiple congenital abnormalities.
    Balta B; Erdogan M; Ergul AB; Sahin Y; Ozcan A
    Am J Med Genet A; 2017 Oct; 173(10):2798-2802. PubMed ID: 28815864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrowing the deleted region associated with the 15q21 syndrome.
    Pramparo T; Mattina T; Gimelli S; Liehr T; Zuffardi O
    Eur J Med Genet; 2005; 48(3):346-52. PubMed ID: 16179230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.
    Carr CW; Zimmerman HH; Martin CL; Vikkula M; Byrd AC; Abdul-Rahman OA
    Am J Med Genet A; 2011 Jul; 155A(7):1640-5. PubMed ID: 21626678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial deletion of the long arm of chromosome 5 in a boy with multiple congenital anomalies and mental retardation: Molecular characterization of the deleted region to 5q22.3q23.3.
    Garcia-Miñaur S; Ramsay J; Grace E; Minns RA; Myles LM; FitzPatrick DR
    Am J Med Genet A; 2005 Feb; 132A(4):402-10. PubMed ID: 15742475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5q14.3 deletion neurocutaneous syndrome: Contiguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C: A progressive disease.
    Ilari R; Agosta G; Bacino C
    Am J Med Genet A; 2016 Mar; 170(3):688-93. PubMed ID: 26774077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An emerging phenotype of proximal 11q deletions.
    Melis D; Genesio R; Cozzolino M; Del Giudice E; Mormile A; Imperati F; Ronga V; Della Casa R; Nitsch L; Andria G
    Eur J Med Genet; 2010; 53(5):340-3. PubMed ID: 20688202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.